Fed. Circ. Reverses Apotex's PTAB Win On OSI Cancer Drug
The Federal Circuit on Friday revived part of an OSI Pharmaceuticals patent that covers the cancer treatment Tarceva, reversing a decision from the Patent Trial and Appeal Board....To view the full article, register now.
Already a subscriber? Click here to view full article